• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore June 18 Kolkata-based TCG Lifesciences has partnered with Forest Laboratories Holdings to discover small molecule drug candidates for inflammatory diseases. Chemiotek, the chemistry and biology arm of TCG, will carry out this discovery research to identify and optimise lead molecules.

Forest will have full ownership of compounds developed under the collaboration with unencumbered worldwide rights and will fund all subsequent drug development and commercialisation activities.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals | Research & Development

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Cairn asked to work out appraisal programme

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line